Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, today announced the first AI-designed molecule for immuno-oncology to …
Link to Full Article: Read Here
Apr 9, 2021 | News Stories
Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, today announced the first AI-designed molecule for immuno-oncology to …
Link to Full Article: Read Here